Apr 7, 2020 | Articles, Case Study, Company News
Exom Group is proud to announce that the results of CARAVAGGIO, a practice-changing study, have been presented at the ACC Virtual 2020 and published on the NEJM on March 29th, 2020. DOI: 10.1056/NEJMoa1915103 The study involved 159 clinical sites distributed in 9...
Mar 17, 2020 | Articles, Clinical Trial News, Company News, Genius Suite
The clinical trials sector is going through a challenging and delicate phase, that could lead to a slowdown in drug development in general. In an attempt to limit damage, safeguard the validity of the data and protect the health of patients by guaranteeing their...
Mar 6, 2020 | Articles, Genius Suite
Even before the crisis hit, there had been a push towards the digitization of clinical research, but this epidemic brings with it a greater urgency. The implementation of digital technologies such as remote monitoring of patients and eSource for collecting and...
